홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

trans-3,4-Difluorocinnamic acid → 1-[(e)-3-(3,4-Difluoro-phenyl)-acryloyl]-4-(3-piperidin-1-yl-propyl)-[1,4]diazepan-5-one

HRID 1867412
인쇄

반응식

HRID 1867412 반응식
ClC1C=C(/C=C/C(N2CCC(=O)NCC2)=O)C=CC=1Cl.[F:21][C:22]1[CH:23]=[C:24]([CH:30]=[CH:31][C:32]=1[F:33])/[CH:25]=[CH:26]/[C:27]([OH:29])=O.Cl.Cl.[N:36]1([CH2:42][CH2:43][CH2:44][N:45]2[C:51](=[O:52])[CH2:50][CH2:49][NH:48][CH2:47][CH2:46]2)[CH2:41][CH2:40][CH2:39][CH2:38][CH2:37]1>>[F:21][C:22]1[CH:23]=[C:24](/[CH:25]=[CH:26]/[C:27]([N:48]2[CH2:49][CH2:50][C:51](=[O:52])[N:45]([CH2:44][CH2:43][CH2:42][N:36]3[CH2:37][CH2:38][CH2:39][CH2:40][CH2:41]3)[CH2:46][CH2:47]2)=[O:29])[CH:30]=[CH:31][C:32]=1[F:33]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 2733300trans-3,4-Difluorocinnamic acidHCID 620449211-[(E)-3-(3,4-Dichloro-phenyl)-acryloyl]-[1,4]diazepan-5-oneHCID 670807474-(3-Piperidin-1-yl-propyl)-[1,4]diazepan-5-one dihydrochloride2회

생성물 1

HCID 684349441-[(e)-3-(3,4-Difluoro-phenyl)-acryloyl]-4-(3-piperidin-1-yl-propyl)-[1,4]diazepan-5-one

실험 절차

In analogy to the procedure described in intermediate 1A, (E)-3,4-difluorocinnamic acid and 4-(3-piperidin-1-yl-propyl)-[1,4]diazepan-5-one-dihydrochloride (intermediate 4B, suspended in CH2Cl2 with 4 equivalent of Et3N) gave after purification on catridges, Si-Amine, 70 ml, 20 g (EtOAc) the title compound as a white powder. MS: 406.2 (MH+).

후처리

  1. customgave
  2. customafter purification on catridges, Si-Amine, 70 ml, 20 g (EtOAc) the title compound as a white powder

출처 및 근거

ORD 기록
ord-12012dab71db4d73a74ed26fc5bb68a6
출처 데이터셋
uspto-grants-2009_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07632829B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트